ARFFX | JVMTX | ARFFX / JVMTX | |
Total Expense Ratio | 1.00 | 1.00 | 100% |
Annual Report Gross Expense Ratio | 1.18 | 1.11 | 106% |
Fund Existence | 20 years | 12 years | - |
Gain YTD | -5.734 | 3.456 | -166% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 60.7M | 21.8B | 0% |
Annual Yield % from dividends | 1.17 | 0.71 | 165% |
Returns for 1 year | -0.27 | -4.36 | 6% |
Returns for 3 years | -4.03 | 12.71 | -32% |
Returns for 5 years | 50.34 | 61.31 | 82% |
Returns for 10 years | 18.29 | 35.64 | 51% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XTJA | 27.94 | -0.37 | -1.29% |
Innovator US Equity Acclrtd Pls ETF Jan | |||
USSE | 30.82 | -0.60 | -1.91% |
Segall Bryant & Hamill Select Equity ETF | |||
CHI | 10.20 | -0.21 | -2.02% |
Calamos Convertible Opportunities and Income Fund | |||
EPRF | 17.32 | -0.36 | -2.04% |
Innovator S&P Investment Grade Prfrd ETF | |||
IBB | 121.69 | -2.98 | -2.39% |
iShares Biotechnology ETF |